Nalaganje...
Effect of route of administration of human recombinant Factor VIII on its immunogenicity in Hemophilia A mice
Factor VIII is a multi-domain glycoprotein and is an essential cofactor in the blood coagulation cascade. Its deficiency or dysfunction causes Hemophilia A, a bleeding disorder. Replacement using exogenous recombinant Factor VIII (FVIII) is the first line of therapy for Hemophilia A. Immunogenicity,...
Shranjeno v:
| Main Authors: | , , , , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2009
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2796435/ https://ncbi.nlm.nih.gov/pubmed/19499565 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jps.21765 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|